Albert W Girotti

Plain English
Researchers studied how photodynamic therapy (a cancer treatment using light-activated drugs) kills not just the cells it directly targets, but also nearby untreated cancer cells through chemical signals. They found that the good bystander effect—where treated cells trigger neighboring cells to die—works through a process called ferroptosis (a type of cell death caused by fat damage), while a bad bystander effect that helps tumors grow is driven by a molecule called nitric oxide. To make this therapy work better, the researchers propose blocking the enzyme that produces nitric oxide while simultaneously boosting ferroptosis in nearby cells, which would kill more cancer cells and improve cure rates.

Plain English
Researchers tested how a common medical oil (Intralipid) affects a cancer-fighting treatment called photodynamic therapy, which uses light and a drug called BPD to kill ovarian cancer cells. They found that the oil does more than just scatter light—it actually reduces the treatment's effectiveness by soaking up the harmful reactive molecules that kill cancer cells, and the oil itself gets broken down in the process. This matters because doctors currently use this oil to improve light distribution during cancer treatment, but they didn't realize it was simultaneously interfering with how well the treatment actually works.

Plain English
Researchers tested a light-based cancer treatment called photodynamic therapy on ovarian cancer cells that resist standard chemotherapy, and found that the treatment killed cancer cells through two different mechanisms at once—by damaging the fatty molecules inside cells and by triggering a separate death pathway involving a fatty substance called ceramide. The treatment worked equally well regardless of whether the cancer cells were naturally resistant to one type of cell death, suggesting the dual approach gives it a backup plan to kill resistant tumors.

Plain English
Researchers found that when doctors use light-based cancer treatment (photodynamic therapy), cancer cells that survive the treatment produce a chemical called nitric oxide that actually helps them recover, grow, and spread to other parts of the body. This happens because the stressed cancer cells activate a protective response that backfires—the nitric oxide shields the remaining cancer cells from harm instead of destroying them. The researchers say doctors can improve this cancer treatment by blocking the production of nitric oxide, which would prevent surviving cancer cells from getting this protective boost.

Plain English
Cancer cells reprogram how they use fats (lipids) to survive and grow, even in harsh conditions that would kill normal cells. These fats do more than just form cell membranes—they act as chemical messengers that control how cells respond to stress, particularly a type of cellular damage called oxidative stress. By understanding how cancer cells use specific fat-signaling pathways (especially ones called SCAP/SREBP and sphingolipid pathways), researchers can develop better drugs to stop tumors from adapting to cancer treatments.

Plain English
Researchers studied how photodynamic therapy (a cancer treatment using light-activated drugs) damages tumors by creating harmful compounds from fat molecules in cell membranes. They found that these fat-based compounds continue causing damage long after the light treatment ends, but this prolonged damage has been largely ignored by doctors using this therapy. The study shows that cancer cells have abnormal fat metabolism compared to healthy cells, making tumors especially vulnerable to treatments that target these fats—and combining light therapy with a fat-targeting drug significantly improved results.

Plain English
Researchers studied what happens to cancer cells that survive a type of light-based cancer treatment called photodynamic therapy (PDT). They found that surviving cancer cells produce a chemical called nitric oxide that makes them tougher, more mobile, and more likely to spread to other parts of the body—essentially making the remaining cancer more aggressive and harder to kill. The nitric oxide from these surviving cells also spreads to nearby cancer cells that weren't directly treated, making those cells dangerous too. This means PDT's benefits could be undermined unless doctors use additional drugs to block this chemical and prevent the surviving cancer cells from becoming more aggressive.

Plain English
Researchers studied how a damaged form of cholesterol called 7-OOH moves into the mitochondria (the cell's power plants) of testosterone-producing cells in the testis, and they found it causes dangerous chemical damage that blocks testosterone production. They discovered that an enzyme called GPx4 normally protects these cells from this damage, but when they disabled GPx4, the cells became much more vulnerable to the toxic effects of 7-OOH. This matters because it reveals a previously unknown protective mechanism in testis cells and could help explain how oxidative stress damages male fertility.

Plain English
Researchers studied what happens when cancer cells are treated with a light-based therapy called photodynamic therapy (PDT): the treated cells release a chemical called nitric oxide that spreads to nearby untreated cancer cells, causing those bystander cells to grow and spread faster instead of dying. They found that the amount of this bystander effect depends on how much nitric oxide the treated cells produce, and they could recreate the same effect by adding nitric oxide directly to untreated cells. This matters because it reveals a major problem with PDT—the therapy might accidentally make some cancer cells more aggressive—but the good news is that blocking nitric oxide with existing drugs could potentially prevent this harmful side effect.

Plain English
Researchers studied what happens when a cancer treatment called photodynamic therapy (PDT) partially kills cancer cells—they found that surviving cancer cells produce a chemical called nitric oxide that makes nearby untreated cancer cells grow faster and spread more aggressively. This is a problem because it means the treatment could accidentally help the tumor recover and become more dangerous, even though it killed some cancer cells. The researchers suggest that doctors could improve this therapy by adding drugs that block nitric oxide production, preventing the surviving cancer cells from helping their neighbors grow.

Plain English
Researchers studied how damaged fat molecules (created when cell membranes break down under stress) move around inside cells and cause harm—specifically, how proteins that normally manage cholesterol movement can accidentally transport these damaged fats into mitochondria (the cell's power plants), making the damage worse. They found that a protective enzyme called GPx4 can stop this harmful transport and prevent the damage from spreading. This matters because this process is linked to heart disease, brain degeneration, and cancer, so understanding how to block it could lead to new treatments.

Plain English
Researchers studied how a molecule called nitric oxide helps cancer cells survive chemotherapy, radiation, and other cancer treatments—and makes those surviving cells even more aggressive and dangerous. They found that cancer cells that manage to survive these treatments produce extra nitric oxide, which makes them spread faster and invade surrounding tissue more readily, and this aggressive behavior can even spread to nearby cancer cells that weren't directly hit by the treatment. This matters because it explains why some cancers come back stronger after treatment, and the researchers suggest that blocking nitric oxide production could be added to cancer therapies to prevent this dangerous rebound effect.

Plain English
Researchers found that cancer cells produce a chemical called nitric oxide that helps them survive photodynamic therapy—a treatment that uses light to destroy cancer cells. When cancer cells make this chemical, they not only survive the treatment but also become more aggressive and spread more easily. The good news is that blocking this chemical with drugs can make photodynamic therapy work much better.

Plain English
Researchers exposed male reproductive cells to cholesterol mixed with a damaged version of cholesterol (created by oxidative stress), and found that this damaged form gets transported into the cells' mitochondria where it causes harmful chemical reactions that prevent the cells from making the hormone progesterone and eventually kills the cells. The cells have a natural defense enzyme called GPx4 that can neutralize this damage, and when researchers blocked this enzyme, the harm got worse—but when they added a substance that mimicked this enzyme's protective function, the cells recovered.

Plain English
Researchers studied what happens to harmful fat molecules (lipid hydroperoxides) created when cancer cells are treated with light-based therapy—these molecules can either break down harmlessly, trigger dangerous chain reactions that damage cells, or move to other parts of the cell where they cause more damage. The key finding was that these harmful molecules can travel between different cellular membranes, spreading the damage beyond where they were originally created. This matters because it shows that light-based cancer treatment creates more widespread cellular damage than previously understood, which could explain both why the therapy works and what side effects it causes.

Plain English
Researchers reviewed how damaged cholesterol and fats in cell membranes can move between different parts of cells during oxidative stress (when cells are exposed to harmful reactive molecules), potentially causing heart disease, brain degeneration, and cancer. They discovered that a protein normally responsible for transporting cholesterol actually also transports damaged cholesterol to the wrong locations in cells, where it interferes with important processes like hormone production and cholesterol removal from blood vessels. The findings suggest that antioxidant treatments might prevent this harmful transport and reduce disease risk.

Plain English
Researchers reviewed how a cancer treatment called photodynamic therapy works and discovered that tumors use a natural molecule called nitric oxide to survive the treatment and actually become more aggressive afterward. This happens both in the cancer cells that are directly targeted and in nearby cancer cells that weren't targeted, making the therapy less effective overall. The researchers identified this problem and discussed possible drug combinations that could block nitric oxide and make the treatment work much better.

Plain English
Researchers studied how a molecule called nitric oxide helps cancer cells survive photodynamic therapy—a cancer treatment that uses light-activated drugs to damage and kill tumor cells. They found that nitric oxide blocks the damage these drugs cause by stopping a chain reaction of chemical damage to cell membranes, essentially protecting cancer cells from being killed by the treatment. This matters because it explains why photodynamic therapy sometimes fails to work as well as expected, and it points to new ways doctors could combine this treatment with other drugs to prevent nitric oxide from interfering and make the therapy more effective at destroying tumors.

Plain English
Researchers studied why a promising light-based cancer treatment (photodynamic therapy) fails against aggressive brain tumors called glioblastomas—specifically, they found that tumor cells produce a chemical called nitric oxide that helps them survive the treatment and grow back even more aggressively afterward. The team identified the exact chain of events inside the cancer cells that triggers this protective nitric oxide production when exposed to the light therapy. They discovered that a drug called JQ1 can block this protective mechanism, which means combining JQ1 with the light treatment should make the therapy much more effective at killing glioblastoma cells.

Plain English
Researchers studied glioblastoma (an aggressive brain cancer) treated with photodynamic therapy—a technique that uses light to activate a drug that kills cancer cells. They discovered that when this light treatment stressed the cancer cells, the cells produced a molecule called nitric oxide that actually protected them from dying and made the surviving cells spread more aggressively. This matters because it explains why photodynamic therapy sometimes fails against this cancer, and it suggests that combining this light treatment with drugs that block nitric oxide production could make the therapy much more effective.

Plain English
Researchers studied how a cancer treatment called photodynamic therapy (PDT) kills tumor cells by creating damaging molecules called free radicals that attack cell membranes, and they discovered that cancer cells can protect themselves by producing nitric oxide—a natural chemical that stops these damaging reactions. The team found that when they added nitric oxide to their experiments, it blocked the chain reaction of damage to cell membranes by interceding with the harmful free radicals, acting like a safety mechanism that prevented the therapy from working effectively. This matters because it reveals why some aggressive cancers are resistant to photodynamic therapy: cancer cells are actively producing nitric oxide to defend themselves, so blocking this defense mechanism could make the treatment much more effective.

Plain English
Researchers discovered that photodynamic therapy—a cancer treatment that uses light to kill tumor cells—accidentally triggers cancer cells to produce more of a chemical called nitric oxide, which actually helps the cancer survive and spread more aggressively. The surviving cancer cells and nearby healthy cells that weren't directly targeted both became more dangerous after treatment, activating proteins that promote cancer growth and survival. The good news is that blocking nitric oxide production with specific drugs could make photodynamic therapy work better and prevent these harmful side effects.

Plain English
Researchers studied a cancer treatment called photodynamic therapy (PDT), which uses light-activated drugs to kill tumors, and discovered that cancer cells defend themselves by producing a substance called nitric oxide that makes them harder to kill. They found this happened in breast, prostate, and brain cancers in lab tests and in actual tumors in mice, and that the surviving cancer cells became more aggressive and spread faster. The nitric oxide also encouraged nearby untargeted cancer cells to grow and spread, which means this defense mechanism could significantly undermine PDT's effectiveness and might be overcome using drugs that block nitric oxide production.

Plain English
Researchers treated cancer cells with a light-based therapy called photodynamic therapy and found that surviving treated cells released a chemical called nitric oxide, which then encouraged nearby untreated cancer cells to grow and spread faster. The effect was stronger in some cancer types (prostate and breast) than others (brain and skin). This matters because if this happens in actual tumors, it could undermine the therapy's effectiveness or even make cancer worse—unless doctors find ways to block this chemical signal.

Plain English
Researchers studied how brain tumors called glioblastomas survive a light-based cancer treatment called photodynamic therapy by producing a chemical called nitric oxide that protects them and makes them more aggressive. They found that this protective response depends on a chain of molecular events: the treatment damages a tumor-suppressor protein called PTEN, which then triggers a domino effect of activations that turns on the gene for nitric oxide production, while simultaneously shutting down a protective protein that would normally prevent this. Blocking nitric oxide production or stopping the chain reaction at various points makes the treatment work much better, suggesting these molecular targets could be combined with photodynamic therapy to overcome the tumor's resistance.

Plain English
Researchers studied how a molecule called nitric oxide (NO) helps brain tumors called glioblastomas survive a light-based cancer treatment called photodynamic therapy (PDT). They found that tumors produce NO, which makes them resistant to PDT and causes surviving tumor cells to become more aggressive and spread faster. The solution is to use drugs that block NO production before giving PDT, which should make the light treatment work better.

Plain English
Researchers studied what happens when cholesterol in your body is damaged by light and oxygen—a process that creates harmful compounds called cholesterol hydroperoxides. These damaged cholesterol molecules can damage cell membranes and trigger chemical reactions inside cells that may harm health, but they can also send signals that affect whether cells live or die. The findings matter because cholesterol damage from light and oxygen happens naturally in the body and may contribute to diseases, yet scientists still don't fully understand how these damaged molecules communicate with cells to cause harm—knowledge that could eventually lead to new treatments.

Plain English
Researchers found that when cancer cells are treated with a light-based therapy called photodynamic therapy (PDT), the cancer cells produce a chemical called nitric oxide as a survival mechanism—essentially fighting back against the treatment. This nitric oxide not only helps cancer cells resist the therapy, but also makes the surviving cancer cells more aggressive and likely to spread to other parts of the body. The good news is that blocking the enzyme responsible for making nitric oxide can prevent this resistance and stop the cancer cells from becoming more dangerous.

Plain English
Researchers studied how a cancer drug called JQ1 could improve light-based cancer therapy (PDT) for a deadly brain tumor called glioblastoma. When glioblastoma cells are hit with PDT light treatment, they produce a chemical called nitric oxide that makes surviving cancer cells grow faster, spread more aggressively, and resist death—essentially undoing the therapy's benefits. The team found that JQ1 blocks the production of this harmful nitric oxide by disrupting a specific molecular pathway in the cancer cells, and it does this far more effectively than existing nitric oxide-blocking drugs. Adding JQ1 to PDT therapy stopped surviving cancer cells from becoming more aggressive and dangerous. This matters because it offers a way to make light-based cancer therapy work much better for brain cancer patients by preventing the tumor cells from bouncing back stronger after treatment.

Plain English
Researchers discovered that when cancer cells are treated with a light-based therapy called photodynamic therapy, nearby untreated cancer cells actually start growing faster and spreading more, even though they were never directly exposed to the treatment. The treated cells release a chemical called nitric oxide that triggers this dangerous response in neighboring cells, creating a self-reinforcing cycle that makes the cancer more aggressive. The study suggests that blocking nitric oxide with drugs could prevent this unwanted side effect and improve how well this cancer treatment works.

Plain English
Cholesterol in your cell membranes and in the fatty particles that carry cholesterol through your blood gets damaged when your body is under oxidative stress—essentially when harmful molecules called free radicals attack it. This damage creates unstable cholesterol molecules called hydroperoxides that can spread to other parts of your cells or between different fat particles, amplifying the harm and contributing to diseases like heart disease and a newly discovered form of cell death called ferroptosis.

Plain English
Researchers treated breast cancer tumors with a light-based therapy called photodynamic therapy and discovered that the cancer cells activated a protective molecule called nitric oxide to survive the treatment. When they blocked the production of nitric oxide using drugs, the cancer cells died more readily and tumors shrank significantly better than with light therapy alone. This matters because it identifies a previously unknown escape mechanism that cancer cells use to resist this type of treatment, and it shows that adding nitric oxide-blocking drugs could make photodynamic therapy much more effective against breast cancer.

Plain English
Researchers exposed cancer cells to a light-based treatment and found that untreated cancer cells nearby became more aggressive and grew faster, even though they never touched the treated cells—this happened because the treated cells released a chemical messenger called nitric oxide that triggered growth signals in the bystander cells. Blocking nitric oxide with drugs stopped the bystander cells from becoming more aggressive, suggesting that doctors could potentially use nitric oxide-blocking drugs alongside this light therapy to prevent cancer cells from becoming more dangerous. This discovery is important because previous cancer treatments were known to have similar unwanted side effects on nearby untreated cells, but nobody had documented this specific problem with light-based therapy before.

Plain English
Researchers studied how a cancer treatment called photodynamic therapy works and discovered that cancer cells fight back against it by producing a molecule called nitric oxide, which blocks the treatment's effectiveness and makes surviving cancer cells more aggressive and likely to spread. The study found this happens in multiple ways: nitric oxide helps cancer cells resist death from the treatment, makes remaining cancer cells grow and move faster, and can even trigger nearby untargeted cancer cells to become more aggressive too. The research suggests that combining this cancer treatment with drugs that block nitric oxide production could prevent these harmful side effects and make the therapy more effective.

Plain English
Researchers studied how a molecule called nitric oxide interferes with photodynamic therapy, a cancer treatment that uses light to destroy tumor cells. They found that cancer cells produce nitric oxide after being exposed to this therapy, which protects them from being killed and actually makes surviving cancer cells more aggressive and likely to spread. Adding drugs that block nitric oxide production to photodynamic therapy could make the treatment more effective at actually killing cancer cells and preventing them from coming back stronger.

Plain English
Researchers tested a new light-based cancer treatment called photodynamic therapy on aggressive brain tumor cells and discovered that the tumor cells produce a protective chemical called nitric oxide that actually helps them survive the treatment. When they blocked this protective chemical with drugs, the cancer cells died more effectively and were less likely to spread. The study shows that adding nitric oxide-blocking drugs to photodynamic therapy could make this treatment much more effective against brain tumors.

Plain English
Researchers developed a new way to measure how much damage free radicals cause to fats in cells and blood by tracking what happens to cholesterol when it gets attacked. They used radioactively labeled cholesterol and a special detection method to identify the specific damaged cholesterol products that form over time in various biological systems like cell membranes and blood lipoproteins. This matters because it's a more accurate way to assess cellular damage from free radicals without using artificial measurement tools that can skew results—giving doctors and scientists a clearer picture of oxidative stress in living systems.

Plain English
Researchers studied why some cancer cells survive photodynamic therapy (a light-based cancer treatment) and found that these surviving cells produce high levels of a molecule called nitric oxide, which makes them grow faster and spread more aggressively. The cancer cells deliberately ramp up nitric oxide production after the light treatment as a defense mechanism, and this allows them to recover and become more dangerous. The good news is that blocking nitric oxide with certain drugs could make the light therapy work better and prevent cancer cells from bouncing back stronger.

Plain English
Researchers studied how oxidative stress (cellular damage from unstable molecules) affects the ability of immune cells called macrophages to remove excess cholesterol from artery walls. They discovered that a specific type of damaged cholesterol called 7-OOH enters macrophage mitochondria and causes toxic damage that shuts down the cholesterol-removal process, preventing these cells from exporting cholesterol out of the body. This matters because people with obesity and high blood pressure experience chronic oxidative stress, which produces this toxic cholesterol form—so their immune cells become trapped with excess cholesterol, leading to plaque buildup and heart disease.

Plain English
Researchers treated prostate cancer cells with a light-based therapy designed to kill them, but found that the cells that survived actually became more aggressive—they multiplied faster, moved more readily, and invaded surrounding tissue more effectively than untreated cancer cells. The survival boost was driven by a molecule called nitric oxide that the stressed cells produced in response to the treatment. Blocking this nitric oxide with drugs prevented the cancer cells from becoming more dangerous, suggesting that doctors could improve this type of light-based therapy by adding nitric oxide-blocking medications to prevent treated tumors from becoming more aggressive.

Plain English
Researchers reviewed decades of attempts to use light-based therapy (PDT) to treat deadly brain tumors, and found that while the technique shows some promise, it still isn't good enough to replace standard treatments like surgery and radiation. The light can only kill tumor cells about 5 millimeters deep, and different drug and light combinations produce mixed results—some approaches work better than others, but none yet match what doctors already do. Scientists are continuing to test these light-based approaches because they could eventually reduce how much damage treatment does to healthy brain tissue, but more large-scale clinical trials are needed to prove they actually work better than current methods.

Plain English
Researchers studied how cancer tumors use a naturally occurring molecule called nitric oxide to survive and resist a cancer treatment called photodynamic therapy (PDT), which uses light to destroy cancer cells. They found that when cancer cells are exposed to PDT, they produce even more nitric oxide, which helps them survive the treatment, grow faster, and spread to other parts of the body. The study matters because blocking nitric oxide production with drugs could make PDT treatments much more effective at killing cancer cells and preventing them from coming back.

Plain English
Researchers studied how a protein called SCP-2 moves harmful cholesterol molecules (created when cells are stressed) around inside cells, and whether this movement causes damage. They found that cells with extra SCP-2 protein were more likely to be damaged by these harmful cholesterol molecules because the protein was delivering them directly to the cell's power plants (mitochondria). Why it matters: This explains one way that oxidative stress—a problem linked to aging, heart disease, and cancer—damages cells, and identifies a potential target for protecting cells from this damage.

Plain English
Researchers discovered that a protein called GPX4 controls a special way to kill cancer cells called ferroptosis, which is different from the normal cell death pathway. They tested 12 different drugs that trigger ferroptosis and found that all of them work by disabling GPX4, and that cancer cells with more GPX4 are resistant to these drugs while cells with less GPX4 are more vulnerable. This matters because certain cancers—particularly lymphomas and kidney cancers—are highly sensitive to ferroptosis, meaning GPX4-targeting drugs could be an effective new treatment option for these patients.

Plain English
Researchers studied how cells remove excess cholesterol from arteries—a process that helps prevent heart disease—and found that under stressful conditions, a protein called StarD1 accidentally transports harmful oxidized cholesterol into the cell's power plants (mitochondria) instead of just regular cholesterol. This damaged the mitochondria and shut down the cholesterol removal process, essentially jamming up the system that's supposed to protect us from heart disease. This discovery matters because it explains why people under chronic stress or with inflammatory diseases have worse cholesterol control and higher heart disease risk.

Plain English
Researchers exposed prostate cancer cells to a light-based cancer treatment called photodynamic therapy, which damages cells by creating harmful molecules. The cancer cells responded by producing a protective substance called nitric oxide that stopped them from dying and actually made surviving cells grow twice as fast as normal. This is a major problem for the treatment's effectiveness because it means the cancer cells are fighting back against the therapy designed to kill them. The researchers identified that blocking nitric oxide production could prevent this protective response and slow the cancer cells' regrowth. This matters because it suggests doctors could improve photodynamic therapy outcomes by combining it with drugs that block nitric oxide, preventing cancer cells from escaping the treatment and multiplying again.

Plain English
Researchers created a new form of doxorubicin, a powerful cancer drug, that stays inactive in the body until exposed to specific light. When injected into cancer patients and then targeted with ultraviolet light at the tumor site, the drug activates only where it's needed, sparing healthy tissue from damage. This approach could finally solve the major problem with doxorubicin: severe side effects caused when it damages the entire body instead of just the cancer.

Plain English
Researchers found that when cells that make sex hormones are stimulated, they produce proteins that actively transport damaged cholesterol (cholesterol with extra oxygen attached) into the cell's power plants (mitochondria), where it causes destructive free radical damage instead of being used to make hormones. When these hormone-making cells were exposed to this damaged cholesterol, the stimulated cells took in much more of it, their mitochondria lost the ability to function, and the cells died—but knocking down the transport protein stopped this damage from happening. This matters because it explains how oxidative stress (an imbalance of damaging molecules in cells) can break down the body's ability to produce hormones like testosterone and progesterone, which could help explain hormone problems related to aging, infertility, or metabolic disease.

Plain English
Researchers studied how cancer cells protect themselves when treated with a light-based cancer therapy called photodynamic therapy (PDT). They found that when cancer cells are stressed by this treatment, they produce a molecule called nitric oxide that acts like a shield, helping the cancer cells survive by activating protective pathways and shutting down death signals. The discovery matters because it explains why some cancer cells resist PDT—they're essentially fighting back with their own survival chemistry. By blocking the production of nitric oxide with drugs, researchers could strip away this shield and make the cancer cells much more vulnerable to being killed by the therapy.